SCHEMBL493306

SCHEMBL493306

C=CCC1(O)C(c2ccc(CC)cc2)[C@]2(O)[C@](O)([C@H](O)CO)C(c3ccc(CC)cc3)[C@]12O

nearest known ligand 0.00

⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL1274687 0.85
SCHEMBL6461064 0.75 SLC5A2 (0.32)
SCHEMBL379855 0.73 SLC5A2 (0.32)
SCHEMBL1274689 0.72
SCHEMBL2915501 0.71 SLC5A2 (0.31)
SCHEMBL812905 0.69 SLC5A2 (0.32)
SCHEMBL815322 0.69 ADCY2 (0.32)
SCHEMBL1221653 0.69 SLC5A2 (0.32)
SCHEMBL812632 0.69 ADCY2 (0.32)
SCHEMBL813371 0.69 SLC5A2 (0.32)

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 39 patents — showing the first 20. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-9421266-B2 Safety of pseudoephedrine drug products PISGAH LABORATORIES, INC. (US) 2016-08-23 US claimed
EP-2075282-B1 Method to improve cold flow resistance of polymers BRIDGESTONE CORP (JP) 2016-01-06 EP claimed
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS PISGAH LABORATORIES, INC. 2014-06-26 US claimed
US-8138248-B2 Method to improve cold flow resistance of polymers BRIDGESTONE CORPORATION (JP) 2012-03-20 US claimed
US-8106117-B2 Method to improve cold flow resistance of polymers BRIDGESTONE CORPORATION (JP) 2012-01-31 US claimed
US-20100036026-A1 METHOD TO IMPROVE COLD FLOW RESISTANCE OF POLYMERS BRIDGESTONE CORPORATION (JP) 2010-02-11 US claimed
US-20100004361-A1 METHOD TO IMPROVE COLD FLOW RESISTANCE OF POLYMERS BRIDGESTONE CORPORATION (JP) 2010-01-07 US claimed
EP-2075282-A1 Method to improve cold flow resistance of polymers Bridgestone Corporation (JP) 2009-07-01 EP claimed
US-20050239928-A1 Acetal-based compositions MILLIKEN & COMPANY 2005-10-27 US claimed
US-20050239926-A1 Method of nucleating a polyolefin composition with acetal-based compounds MILLIKEN & COMPANY 2005-10-27 US claimed
US-9421266-B2 Safety of pseudoephedrine drug products PISGAH LABORATORIES, INC. (US) 2016-08-23 US disclosed
EP-2075282-B1 Method to improve cold flow resistance of polymers BRIDGESTONE CORP (JP) 2016-01-06 EP disclosed
EP-1924640-B1 SILICA-CONTAINING NUCLEATING AGENT COMPOSITIONS AND METHODS FOR USING SUCH COMPOSITIONS IN POLYOLEFINS MILLIKEN & CO (US) 2014-12-31 EP disclosed
US-20140178480-A1 SAFETY OF PSUEDOEPHEDRINE DRUG PRODUCTS PISGAH LABORATORIES, INC. 2014-06-26 US disclosed
US-8138248-B2 Method to improve cold flow resistance of polymers BRIDGESTONE CORPORATION (JP) 2012-03-20 US disclosed
US-20060173108-A1 Co-additive compositions and methods for applying co-additive compositions into nucleated polymer compounds MILLIKEN & COMPANY 2006-08-03 US disclosed
US-20060173109-A1 Method and compositions for reducing plate-out in the manufacture of plastic articles MILLIKEN & COMPANY, M-495 2006-08-03 US disclosed
US-20060079720-A1 Method for preparing acetal-containing compositions MILLIKEN & COMPANY 2006-04-13 US disclosed
US-20050239926-A1 Method of nucleating a polyolefin composition with acetal-based compounds MILLIKEN & COMPANY 2005-10-27 US disclosed
US-20050239928-A1 Acetal-based compositions MILLIKEN & COMPANY 2005-10-27 US disclosed